LPT
BIIB icon

Legacy Private Trust’s Biogen BIIB Stock Holding History

Legacy Private Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,102
Closed -$270K – 216
2020
Q4 		$270K Buy
+1,102
New +$284K 0.03% 211
2019
Q1 		– Sell
-4,009
Closed -$1.21M – 220
2018
Q4 		$1.21M Sell
4,009
-3,005
-43% -$959K 0.16% 118
2018
Q3 		$2.48M Buy
7,014
+197
+3% +$67.8K 0.28% 84
2018
Q2 		$1.98M Buy
6,817
+84
+1% +$23.6K 0.24% 96
2018
Q1 		$1.84M Buy
6,733
+1,531
+29% +$475K 0.22% 98
2017
Q4 		$1.66M Buy
5,202
+2,985
+135% +$958K 0.19% 102
2017
Q3 		$694K Buy
2,217
+637
+40% +$189K 0.08% 161
2017
Q2 		$429K Sell
1,580
-1,640
-51% -$434K 0.05% 177
2017
Q1 		$880K Sell
3,220
-1,015
-24% -$287K 0.11% 147
2016
Q4 		$1.2M Sell
4,235
-3,875
-48% -$1.15M 0.16% 126
2016
Q3 		$2.54M Buy
8,110
+4,480
+123% +$1.33M 0.35% 79
2016
Q2 		$878K Sell
3,630
-470
-11% -$124K 0.13% 136
2016
Q1 		$1.07M Buy
4,100
+160
+4% +$42.3K 0.16% 127
2015
Q4 		$1.21M Sell
3,940
-240
-6% -$69K 0.18% 122
2015
Q3 		$1.22M Sell
4,180
-350
-8% -$116K 0.19% 123
2015
Q2 		$1.83M Sell
4,530
-1,610
-26% -$646K 0.28% 98
2015
Q1 		$2.59M Buy
6,140
+330
+6% +$130K 0.38% 76
2014
Q4 		$1.97M Sell
5,810
-80
-1% -$25.9K 0.29% 88
2014
Q3 		$1.95M Sell
5,890
-170
-3% -$56.1K 0.3% 91
2014
Q2 		$1.91M Sell
6,060
-20
-0.3% -$6.02K 0.3% 96
2014
Q1 		$1.86M Sell
6,080
-290
-5% -$92.1K 0.32% 82
2013
Q4 		$1.78M Buy
6,370
+550
+9% +$142K 0.33% 79
2013
Q3 		$1.4M Sell
5,820
-2,400
-29% -$537K 0.3% 77
2013
Q2 		$1.77M Buy
+8,220
New +$1.76M 0.42% 60

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legacy Private Trust's BIIB Position: Q1 2021 in Review

Legacy Private Trust sold out of Biogen (BIIB) in Q1 2021, closing a stake of 1,102 shares — an estimated $270K sold.

Legacy Private Trust first reported a position in BIIB in Q2 2013 and held it in 24 quarters. The position peaked at $2.59M in Q1 2015. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Legacy Private Trust reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Legacy Private Trust sold 1,102 Biogen shares in Q1 2021, an estimated $270K.
  • Legacy Private Trust first reported a position in Biogen in Q2 2013 and held it in 24 quarters.
  • Legacy Private Trust's Biogen position peaked at $2.59M in Q1 2015.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Legacy Private Trust's 13F filing for Q1 2021, filed 9 Apr 2021.